<DOC>
	<DOCNO>NCT00358943</DOCNO>
	<brief_summary>The ICGG Gaucher Registry ongoing , international multi-center , strictly observational program track routine clinical outcome patient Gaucher disease , irrespective treatment status . No experimental intervention involve ; patient Registry undergo clinical assessment receive care determine patient 's treating physician . The objective Registry : - To enhance understanding variability , progression , natural history Gaucher disease ultimate goal well guide assess therapeutic intervention ; - To provide Gaucher medical community recommendation monitor patient provide report patient outcome help optimize patient care ; - To evaluate long-term effectiveness Cerezyme .</brief_summary>
	<brief_title>International Collaborative Gaucher Group ( ICGG ) Gaucher Registry</brief_title>
	<detailed_description />
	<mesh_term>Gaucher Disease</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Lipidoses</mesh_term>
	<criteria>All patient confirm diagnosis Gaucher disease eligible inclusion Registry . Confirmed diagnosis define documented βglucocerebrosidase deficiency and/or mutation βglucocerebrosidase gene . For patient , appropriate patient authorization obtain . No exclusion criterion participation ICGG Gaucher Registry.NOTE : Registry participation exclude participation clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Gaucher Disease</keyword>
	<keyword>Glucocerebrosidase Deficiency Disease</keyword>
</DOC>